ArticleMolecular diversity2026
Synthesis and antifungal activity evaluation of flavonol derivatives containing an imidazolidinone moiety.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Phytopathogenic fungi pose a major threat to crop production and food safety, driving an urgent need for novel, highly effective, and environmentally friendly antifungal agents. To address this need, 22 flavonol derivatives incorporating imidazolidinone pharmacophore were designed and synthesized, and their antifungal activities were systematically evaluated against seven plant pathogenic fungi. Among them, H7 was selected as a candidate compound due to its superior activity, exhibiting a half-maximal effective concentration (EC
Indexed as
Identifiers
42568009What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.